FI882705A - Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä - Google Patents

Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä Download PDF

Info

Publication number
FI882705A
FI882705A FI882705A FI882705A FI882705A FI 882705 A FI882705 A FI 882705A FI 882705 A FI882705 A FI 882705A FI 882705 A FI882705 A FI 882705A FI 882705 A FI882705 A FI 882705A
Authority
FI
Finland
Prior art keywords
aminoacylates
preparation
glycerol acetal
pharmacologically useful
pharmacologically
Prior art date
Application number
FI882705A
Other languages
English (en)
Swedish (sv)
Other versions
FI882705A0 (fi
FI90421C (fi
FI90421B (fi
Inventor
Colette Broquet
Pierre Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of FI882705A0 publication Critical patent/FI882705A0/fi
Publication of FI882705A publication Critical patent/FI882705A/fi
Application granted granted Critical
Publication of FI90421B publication Critical patent/FI90421B/fi
Publication of FI90421C publication Critical patent/FI90421C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI882705A 1987-06-12 1988-06-08 Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä FI90421C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878713745A GB8713745D0 (en) 1987-06-12 1987-06-12 Aminoacylates of glycerol
GB8713745 1987-06-12

Publications (4)

Publication Number Publication Date
FI882705A0 FI882705A0 (fi) 1988-06-08
FI882705A true FI882705A (fi) 1988-12-13
FI90421B FI90421B (fi) 1993-10-29
FI90421C FI90421C (fi) 1994-02-10

Family

ID=10618794

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882705A FI90421C (fi) 1987-06-12 1988-06-08 Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä

Country Status (33)

Country Link
US (1) US4921865A (fi)
JP (1) JPH0615540B2 (fi)
KR (1) KR960005153B1 (fi)
AR (1) AR245121A1 (fi)
AT (1) AT396236B (fi)
AU (1) AU621298B2 (fi)
BE (1) BE1000700A4 (fi)
CA (1) CA1337297C (fi)
CH (1) CH674516A5 (fi)
DE (1) DE3819829C2 (fi)
DK (1) DK319188A (fi)
DZ (1) DZ1215A1 (fi)
ES (1) ES2009283A6 (fi)
FI (1) FI90421C (fi)
FR (2) FR2616326B1 (fi)
GB (1) GB8713745D0 (fi)
GR (1) GR1000889B (fi)
HK (1) HK77191A (fi)
IE (1) IE61447B1 (fi)
IN (1) IN172782B (fi)
IT (1) IT1218067B (fi)
LU (1) LU87235A1 (fi)
MA (1) MA21298A1 (fi)
MY (1) MY103577A (fi)
NL (1) NL192521C (fi)
NO (1) NO170632C (fi)
NZ (1) NZ224936A (fi)
OA (1) OA08879A (fi)
PT (1) PT87689B (fi)
SE (1) SE466450B (fi)
SG (1) SG73191G (fi)
TN (1) TNSN88057A1 (fi)
ZA (1) ZA884024B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2556849B2 (ja) * 1986-02-13 1996-11-27 三共株式会社 グリセリン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035178A (en) * 1976-08-31 1977-07-12 Fmc Corporation Herbicidal 1,3-dioxanes
IN146343B (fi) * 1976-08-31 1979-05-05 Fmc Corp
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use
GB8612940D0 (en) * 1986-05-28 1986-07-02 Dow Chemical Co Derivative esters

Also Published As

Publication number Publication date
KR960005153B1 (ko) 1996-04-22
SE466450B (sv) 1992-02-17
SE8802162D0 (sv) 1988-06-09
NO170632C (no) 1992-11-11
NZ224936A (en) 1990-03-27
TNSN88057A1 (fr) 1990-07-10
IE881752L (en) 1988-12-12
AR245121A1 (es) 1993-12-30
IE61447B1 (en) 1994-11-02
FR2616432B1 (fr) 1990-05-11
DK319188D0 (da) 1988-06-10
SG73191G (en) 1991-11-22
NO882564D0 (no) 1988-06-10
FR2616432A1 (fr) 1988-12-16
JPS6413085A (en) 1989-01-17
PT87689B (pt) 1992-09-30
DZ1215A1 (fr) 2004-09-13
ATA152988A (de) 1992-11-15
FI882705A0 (fi) 1988-06-08
DE3819829A1 (de) 1988-12-22
FR2616326A1 (fr) 1988-12-16
FI90421C (fi) 1994-02-10
MA21298A1 (fr) 1988-12-31
IT1218067B (it) 1990-04-12
ES2009283A6 (es) 1989-09-16
AU621298B2 (en) 1992-03-12
CA1337297C (en) 1995-10-10
NO170632B (no) 1992-08-03
ZA884024B (en) 1989-02-22
MY103577A (en) 1993-08-28
FI90421B (fi) 1993-10-29
IN172782B (fi) 1993-11-27
NL8801484A (nl) 1989-01-02
CH674516A5 (fi) 1990-06-15
GR1000889B (el) 1993-03-16
DK319188A (da) 1989-02-03
GB8713745D0 (en) 1987-07-15
JPH0615540B2 (ja) 1994-03-02
PT87689A (pt) 1988-07-01
DE3819829C2 (de) 1993-10-21
OA08879A (fr) 1989-10-31
GR880100363A (en) 1989-03-08
NO882564L (no) 1988-12-13
HK77191A (en) 1991-10-11
KR890000471A (ko) 1989-03-14
AT396236B (de) 1993-07-26
FR2616326B1 (fr) 1989-12-01
US4921865A (en) 1990-05-01
BE1000700A4 (fr) 1989-03-14
NL192521C (nl) 1997-09-02
IT8820940A0 (it) 1988-06-10
AU1756288A (en) 1988-12-15
SE8802162L (sv) 1988-12-13
NL192521B (nl) 1997-05-01
LU87235A1 (fr) 1988-12-13

Similar Documents

Publication Publication Date Title
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI882007A (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
FI891538A (fi) Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi
FI881223A (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI892182A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI850654A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten pleuromutilinijohdannaisten valmistamiseksi
PT86687A (pt) Process for the preparation of novel polyamine derivatives
FI895048A0 (fi) Menetelmä farmakologisesti aktiivisten 4-amino-3-asyylikinoliinijohdannaisten valmistamiseksi sekä uusia välituotteita
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI882669A0 (fi) Menetelmä farmaseuttisesti aktiivisten alfa-halogenoitujen dikarboksyylihappojen valmistamiseksi
FI884910A (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI892948A (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI902727A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI903863A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI880190A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tetrahydrofuraanijohdoksia
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI911855A0 (fi) Menetelmä anti-inflammatorisesti vaikuttavien 3-asyyli-2-oksindoli-1-karboksiamidi-esilääkkeiden valmistamiseksi
FI882705A (fi) Glyseroliasetaalin farmakologisesti käyttökelpoisten aminoasylaattien valmistusmenetelmä
FI893434A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: SOCIETE DE CONSEILS DE RECHERCHES ET D APPLICATION